Ronan Swords Selected Research

Ronan Swords Research Topics

Disease

11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 10/2009
9	Neoplasms (Cancer) 04/2024 - 10/2006
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2010 - 03/2007
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2024 - 10/2009
4	Leukemia 10/2013 - 10/2006
4	Philadelphia Chromosome 05/2007 - 01/2007
2	Hematologic Neoplasms (Hematological Malignancy) 06/2012 - 10/2009
1	Hematologic Diseases (Blood Diseases) 01/2023
1	Fibrosis (Cirrhosis) 08/2019
1	Splenomegaly 08/2019
1	Primary Myelofibrosis (Myelosclerosis) 08/2019
1	Cytopenia 01/2019
1	Hairy Cell Leukemia 01/2018
1	Acute Promyelocytic Leukemia 02/2013
1	Lymphoma (Lymphomas) 12/2011
1	Adenocarcinoma 12/2011
1	Carcinogenesis 12/2011
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2010
1	Wilms Tumor (Wilm's Tumor) 11/2010
1	Hypoxia (Hypoxemia) 10/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2010
1	Sarcoma (Soft Tissue Sarcoma) 10/2009
1	Retinoblastoma (Glioblastoma, Retinal) 10/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2009
1	Inflammation (Inflammations) 04/2009
1	Pericardial Effusion 04/2009
1	Acute Biphenotypic Leukemia (Leukemia, Mixed Cell) 11/2007
1	Pain (Aches) 11/2007
1	Bone Diseases (Bone Disease) 11/2007
1	Compression Fractures (Compression Fracture) 11/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2007

Drug/Important Bio-Agent (IBA)

7	Imatinib Mesylate (Gleevec)FDA Link 08/2010 - 01/2007
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 05/2007
3	Phosphotransferases (Kinase)IBA 10/2013 - 03/2007
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2013 - 10/2006
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2010
2	proto-oncogene proteins pimIBA 04/2015 - 12/2011
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 02/2013 - 04/2012
2	5'-oleoyl cytarabineIBA 02/2013 - 04/2012
2	Antineoplastic Agents (Antineoplastics)IBA 02/2012 - 10/2009
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2011 - 03/2007
2	nilotinib FDA Link 09/2009 - 04/2009
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	nuclear pore complex protein 98IBA 01/2022
1	Aurora Kinase AIBA 08/2019
1	MLN 8237IBA 08/2019
1	ruxolitinibIBA 08/2019
1	CytokinesIBA 08/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2018
1	immunotoxin HA22IBA 01/2018
1	Immunotoxins (Immunotoxin)IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2015
1	Polo-Like Kinase 1IBA 04/2015
1	perifosineIBA 10/2013
1	Azacitidine (5 Azacytidine)FDA Link 06/2013
1	LipidsIBA 02/2013
1	Topoisomerase II InhibitorsIBA 02/2013
1	Daunorubicin (Cerubidine)FDA LinkGeneric 02/2013
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2013
1	Eph Family Receptors (Eph Receptors)IBA 06/2012
1	AcidsIBA 04/2012
1	amonafideIBA 02/2012
1	Janus Kinase 2IBA 12/2011
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2011
1	tanespimycin (17AAG)IBA 11/2010
1	STA 9090IBA 11/2010
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2010
1	Adenosine Triphosphate (ATP)IBA 10/2010
1	SurvivinIBA 01/2010
1	Vorinostat FDA Link 01/2010
1	temsirolimus FDA Link 01/2010
1	TOR Serine-Threonine KinasesIBA 01/2010
1	laromustine (VNP40101M)IBA 10/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2009
1	Alkylating AgentsIBA 10/2009
1	Dasatinib (BMS 354825)FDA Link 04/2009
1	Opiate AlkaloidsIBA 11/2007
1	nelarabine (506U78)FDA Link 11/2007
1	bcr-abl Fusion ProteinsIBA 01/2007
1	troxacitabineIBA 10/2006

Therapy/Procedure

15	Therapeutics 04/2024 - 03/2007
1	Induction Chemotherapy 03/2016
1	Drug Therapy (Chemotherapy) 11/2010
1	Biological Therapy 10/2009
1	Analgesia 11/2007
1	Stem Cell Transplantation 01/2007